Phosphane-Free Palladium-Catalyzed Suzuki Coupling
129.5, 128.9, 128.8, 128.3, 127.6, 127.5, 127.3, 126.6, 126.5, 125.4,
125.3, 125.1, 124.4, 51.1, 51.0, 45.9, 21.3, 20.8, 20.7, 20.6,
FTIR (NaCl, neat): ν = 1634 [CON(C H ) ] cm–1
(400 MHz, CDCl3): δ = 7.51–7.09 (m, 4 H), 7.04–6.41 (m, 1 H),
.
1H NMR
˜
3
7 2
20.5 ppm. GC–MS: m/z (%) = 321.20 (28), 278.11 (6), 221.05 (100), 6.27–5.68 (m, 1 H), 3.64–3.55 (m, 1 H), 3.53–3.50 (m, 1 H), 2.38–
178.02 (50), 114.97 (9), 83.95 (20). HRMS (ESI): Calcd. for
2.15 (m, 2 H), 1.60–1.55 (m, 6 H), 1.26 (s, 14 H), 1.13–1.03 (m, 6
H), 0.88 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 170.5,
137.1, 134.5, 134.0, 133.3, 129.2, 128.1, 127.6, 126.8, 126.6, 125.9,
125.2, 125.2, 125.0, 50.9, 50.8, 45.8, 33.3, 31.9, 30.0, 29.6, 29.3,
29.1, 28.8, 22.7, 20.8, 20.7, 20.6, 20.4, 14.1 ppm. GC–MS: m/z (%)
= 357.38 (100), 314.45 (51), 272.14 (56), 244.23 (50), 230.14 (72),
188.08 (38), 144.99 (79), 131.04 (74), 115.02 (49), 69.06 (57).
HRMS (ESI): Calcd. for [C24H39NO+H]+ 358.3110; found
358.3107.
[C22H27NO+H]+ 322.2171; found 322.2174.
N,N-Diisopropyl-2-(–2-methyl-4-phenylbuta-1,3-dienyl)benzamide
(2e): White solid; yield 70% (mixture of isomers); Rf = 0.4 (ethyl
acetate/hexane, 1:5). FTIR (NaCl, neat): ν = 1626 [CON-
˜
1
(C3H7)2] cm–1. H NMR (400 MHz, CDCl3): δ = 7.45–7.18 (m, 10
H), 6.95–6.59 (m, 2 H), 3.62–3.53 (m, 1 H), 3.49–3.42 (m, 1 H),
2.11–2.07 (m, 3 H), 1.63–1.48 (m, 6 H), 1.03–0.95 (m, 6 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 170.3, 170.3, 138.9, 138.7, 137.6,
137.5, 137.0, 135.7, 133.7, 133.5, 130.7, 129.7, 129.5, 128.7, 128.6,
127.9, 127.7, 127.7, 127.6, 127.5, 127.1, 126.8, 126.7, 126.5, 125.0,
50.9, 50.8, 45.8, 20.9, 20.8, 20.4, 20.3, 20.2, 14.0 ppm. GC–MS: m/z
(%) = 347.26 (100), 304.15 (16), 262.15 (42), 247.10 (71), 229.10
(49), 204.05 (52), 146.01 (76), 91.05 (60). HRMS (ESI): Calcd. for
[C24H29NO+H]+ 348.2327; found 348.2321.
N,N-Diisopropyl-2-(–3-methyl-4-phenylbuta-1,3-dienyl)benzamide
(2k): White solid; yield 65% (mixture of isomers); Rf = 0.4 (ethyl
acetate/hexane, 1:5). FTIR (NaCl, neat): ν = 1628 [CON-
˜
(C3H7)2] cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.80–7.30 (m, 4
H), 7.27–7.18 (m, 4 H), 7.15–7.13 (m, 1 H), 7.00–6.35 (m, 3 H),
3.77–3.60 (m, 1 H), 3.54–3.45 (m, 1 H), 2.22–2.08 (m, 1 H), 1.86
(s, 2 H), 1.64–1.56 (m, 6 H), 1.12–1.04 (m, 6 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 170.2, 138.3, 137.7, 136.5, 135.2, 134.2,
132.4, 130.2, 129.3, 129.1, 128.2, 127.5, 127.2, 126.7, 126.1, 124.7,
51.0, 45.8, 21.0, 20.8, 20.7, 20.5, 20.4, 18.4 ppm. GC–MS: m/z (%)
= 347.26 (70), 332.11 (33), 304.17 (33), 247.07 (100), 203.06 (44),
128.05 (25), 76.99 (6). HRMS (ESI): Calcd. for [C24H29NO+H]+
348.2327; found 348.2325.
N,N-Diisopropyl-2-(2-p-tolylprop-1-enyl)benzamide (2f): Light-yel-
low solid; yield 70% (mixture of isomers); Rf = 0.4 (ethyl acetate/
hexane, 1:5). FTIR (NaCl, neat): ν = 1624 [CON(C H ) ] cm–1. 1H
˜
3
7 2
NMR (400 MHz, CDCl3): δ = 7.41 (d, J = 8 Hz, 1 H), 7.37–7.32
(m, 1 H), 7.28–7.24 (m, 1 H), 7.20–7.14 (m, 1 H), 7.10–7.06 (m, 3
H), 6.94–6.89 (m, 1 H), 6.79–6.48 (m, 1 H), 3.74–3.58 (m, 1 H),
3.75–3.40 (m, 1 H), 2.34 (d, J = 12 Hz, 3 H), 2.18 (dd, J = 8.8 Hz,
3 H), 1.63–1.49 (m, 6 H), 1.20–0.97 (m, 6 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 170.7, 170.4, 140.0, 139.6, 138.5, 138.0,
137.1, 136.8, 133.7, 129.8, 129.6, 129.1, 129.0, 128.0, 127.7, 127.2,
126.8, 126.3, 125.6, 124.9, 124.7, 124.0, 123.2, 51.0, 50.8, 45.9, 45.7,
26.9, 21.2, 21.1, 20.9, 20.8, 20.5, 20.3, 17.1 ppm. GC–MS: m/z (%)
= 335.27 (23), 292.12 (3), 235.08 (100), 221.04 (32), 191.04 (22),
114.97 (28), 76.95 (3). HRMS (ESI): Calcd. for [C23H29NO+H]+
336.2327; found 336.2305.
N,N-Diisopropyl-2-[(2-methylcyclohexylidene)methyl]benzamide
(2l): White solid; yield 60% (mixture of isomers); Rf = 0.4 (ethyl
acetate/hexane, 1:5). FTIR (NaCl, neat): ν = 1628 [CON-
˜
(C3H7)2] cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.26–7.14 (m, 4
H), 6.27–6.13 (m, 1 H), 3.65–3.53 (m, 1 H), 3.50–3.44 (m, 1 H),
3.09–2.69 (m, 1 H), 2.42–1.98 (m, 2 H), 1.81–1.66 (m, 3 H), 1.57–
1.49 (m, 8 H), 1.34–1.22 (m, 4 H), 1.12–1.02 (m, 9 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 170.5, 148.3, 148.2, 148.0, 138.7,
129.9, 129.7, 128.9, 127.5, 127.4, 126.3, 126.2, 126.1, 124.3, 119.2,
117.1, 50.8, 50.7, 45.8, 45.6, 39.2, 38.9, 37.0, 36.7, 33.2, 31.0, 29.7,
29.3, 28.6, 28.4, 28.0, 25.8, 25.5, 21.2, 21.1, 20.8, 20.5, 20.4, 18.8,
18.7 ppm. GC–MS: m/z (%) = 313.20 (49), 270.14 (15), 212.07
(100), 197.03 (44), 156.99 (48), 145.00 (34), 128.00 (30), 114.97 (29),
85.98 (74). HRMS (ESI): Calcd. for [C21H31NO+H]+ 314.2484;
found 314.2468.
2-[(2,3-Dihydroinden-1-ylidene)methyl]-N,N-diisopropylbenzamide
(2g): White solid; yield 56% (mixture of isomers); Rf = 0.4 (ethyl
acetate/hexane, 1:5). FTIR (NaCl, neat): ν = 1626 [CON-
˜
(C3H7)2] cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.61–7.08 (m, 8
H), 6.99–6.13 (m, 1 H), 3.76–3.61 (m, 1 H), 3.51–3.33 (m, 1 H),
3.94–2.13 (m, 4 H), 1.62–1.47 (m, 6 H), 1.13–0.86 (m, 6 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 170.6, 170.5, 145.9, 145.5, 145.0,
144.4, 142.8, 142.4, 138.9, 138.5, 135.4, 134.0, 130.5, 130.1, 128.4,
128.2, 127.9, 127.6, 126.8, 126.5, 126.2, 126.2, 125.3, 125.1, 125.0,
124.7, 123.7, 120.3, 119.6, 115.7, 51.0, 50.9, 45.9, 45.8, 37.8, 31.0,
30.8, 30.6, 20.8, 20.7, 20.6, 20.5, 20.4 ppm. GC–MS: m/z (%) =
333.24 (49), 232.08 (100), 215.06 (89), 178.03 (7), 76.92 (4). HRMS
(ESI): Calcd. for [C23H27NO+H]+ 334.2171; found 334.2169.
2-(But-1-enyl)-N,N-diisopropylbenzamide (2m): White solid; yield
70 % (mixture of isomers); Rf = 0.4 (ethyl acetate/hexane, 1:5).
FTIR (NaCl, neat): ν = 1628 [CON(C H ) ] cm–1 1H NMR
.
˜
3
7 2
(400 MHz, CDCl3): δ = 7.50–7.10 (m, 4 H), 6.45–6.42 (d, J =
12 Hz, 1 H), 6.31–5.69 (m, 1 H), 3.59 (s, 1 H), 3.48 (s, 1 H), 2.29–
2.21 (m, 2 H), 1.58–1.40 (m, 6 H), 1.07–1.04 (m, 9 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 170.5, 170.3, 138.4, 137.1, 135.8,
134.6, 133.9, 133.6, 129.3, 128.1, 127.6, 126.8, 125.6, 125.6, 125.2,
125.1, 124.9, 50.9, 45.8, 45.7, 29.7, 26.1, 22.0, 20.8, 20.7, 20.6, 20.4,
14.3, 13.2 ppm. GC–MS: m/z (%) = 259.16 (36), 216.08 (41), 188.03
(11), 159.02 (35), 131.00 (100), 114.97 (18), 90.96 (24), 76.94 (5).
HRMS (ESI): Calcd. for [C21H31NO+H]+ 260.2014; found
260.2020.
N,N-Diisopropyl-2-(2-phenylprop-1-enyl)benzamide (2h): Yellow oil;
yield 69% (mixture of isomers); Z/E = 60:40; Rf = 0.4 (ethyl ace-
tate/hexane, 1:5). FTIR (NaCl, neat): ν = 1632 [CON(C H ) ] cm–1.
˜
3
7 2
1H NMR (400 MHz, CDCl3): δ = 8.20–7.59 (m, 1 H), 7.53–7.46
(m, 1 H), 7.44–7.37 (m, 1 H), 7.35–7.27 (m, 2 H), 7.20–7.03 (m, 3
H), 6.95–6.87 (m, 1 H), 6.73–6.51 (m, 1 H), 3.85–3.60 (m, 1 H),
3.58–3.41 (m, 1 H), 2.31–2.06 (m, 3 H), 1.65–1.50 (m, 6 H), 1.22–
0.98 (m, 6 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 170.8, 141.6,
139.9, 138.4, 134.3, 133.5, 129.7, 129.6, 128.6, 128.4, 128.1, 127.8,
127.7, 127.4, 127.3, 127.1, 127.0, 126.5, 125.8, 124.9, 124.8, 124.7,
123.4, 51.1, 50.9, 46.0, 45.9, 26.9, 20.8, 20.5, 20.4, 20.3 ppm. GC–
MS: m/z (%) = 321.20 (23), 278.16 (3), 221.05 (100), 203.02 (15),
178.02 (23), 114.96 (28), 76.87 (4). HRMS (ESI): Calcd. for
[C22H27NO+H]+ 322.2171; found 322.2176.
2-(2,2-Di-p-tolylvinyl)-N,N-diisopropyl-4,5-dimethylbenzamide (2n):
White solid; yield 75%; Rf = 0.4 (ethyl acetate/hexane, 1:5). FTIR
1
(NaCl, neat): ν = 1619 [CON(C H ) ] cm–1. H NMR (400 MHz,
˜
3
7 2
CDCl3): δ = 7.25–7.23 (m, 2 H), 7.18 (d, J = 8 Hz, 2 H), 7.07–7.04
(m, 4 H), 6.89 (d, J = Hz, 2 H 8 H), 6.50 (s, 1 H), 3.89–3.82 (m, 1
H), 3.47–3.40 (m, 1 H), 2.32 (s, 6 H), 2.16 (s, 3 H), 1.88 (s, 3 H),
1.57 (d, J = 8 Hz, 3 H), 1.46 (d, J = 8 Hz, 3 H), 1.10 (dd, J = 8,
16 Hz, 6 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 170.9, 142.3,
140.5, 137.6, 137.4, 137.1, 136.9, 135.4, 135.4, 130.8, 130.2, 130.1,
N,N-Diisopropyl-2-(undec-1-enyl)benzamide (2i): Yellow solid; yield
70 % (mixture of isomers); Rf = 0.4 (ethyl acetate/hexane, 1:5).
Eur. J. Org. Chem. 2012, 290–297
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
295